Advertisement
Screener

Intuitive Surgical, Inc. (ISRG) Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent

Intuitive Surgical, Inc. Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent

Intuitive Surgical, Inc. (ISRG) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of $23.30 million for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-10-20.

Discontinued › Income Statement › Unrealized Gains

us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2023-10-20

  • Intuitive Surgical, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2023-09-30 was $23.30M.
  • Intuitive Surgical, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2023-06-30 was $28.70M.
  • Intuitive Surgical, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2023-03-31 was $54.00M.
  • Intuitive Surgical, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2022-09-30 was -$43.40M.
  • Intuitive Surgical, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2021 was -$49.10M, a 492.80% decline from fiscal 2020.
  • Intuitive Surgical, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2020 was $12.50M, a 51.36% decline from fiscal 2019.
  • Intuitive Surgical, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2019 was $25.70M.
Period endOther Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 monthOther Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 monthOther Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 monthOther Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month
2023-09-30$23.30M
10-Q · filed 2023-10-20
$52.00M
derived: sum of 2 quarters · filed 2023-10-20
$106.00M
10-Q · filed 2023-10-20
2023-06-30$28.70M
10-Q · filed 2023-07-24
$82.70M
10-Q · filed 2023-07-24
2023-03-31$54.00M
10-Q · filed 2023-04-20
2022-09-30-$43.40M
10-Q · filed 2023-10-20
-$76.90M
derived: sum of 2 quarters · filed 2023-10-20
-$163.40M
10-Q · filed 2023-10-20
-$192.90M
derived: sum of 4 quarters · filed 2023-10-20
2022-06-30-$33.50M
10-Q · filed 2023-07-24
-$120.00M
10-Q · filed 2023-07-24
-$149.50M
derived: sum of 3 quarters · filed 2023-07-24
-$154.50M
derived: sum of 4 quarters · filed 2023-07-24
2022-03-31-$86.50M
10-Q · filed 2023-04-20
-$116.00M
derived: sum of 2 quarters · filed 2023-04-20
-$121.00M
derived: sum of 3 quarters · filed 2023-04-20
-$122.10M
derived: sum of 4 quarters · filed 2023-04-20
2021-12-31-$29.50M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-03
-$34.50M
derived: sum of 2 quarters · filed 2022-10-21
-$35.60M
derived: sum of 3 quarters · filed 2022-10-21
-$49.10M
10-K · filed 2022-02-03
2021-09-30-$5.00M
10-Q · filed 2022-10-21
-$6.10M
derived: sum of 2 quarters · filed 2022-10-21
-$19.60M
10-Q · filed 2022-10-21
-$10.90M
derived: sum of 4 quarters · filed 2022-10-21
2021-06-30-$1.10M
10-Q · filed 2022-07-22
-$14.60M
10-Q · filed 2022-07-22
-$5.90M
derived: sum of 3 quarters · filed 2022-07-22
-$12.00M
derived: sum of 4 quarters · filed 2022-07-22
2021-03-31-$13.50M
10-Q · filed 2022-04-22
-$4.80M
derived: sum of 2 quarters · filed 2022-04-22
-$10.90M
derived: sum of 3 quarters · filed 2022-04-22
$2.50M
derived: sum of 4 quarters · filed 2022-04-22
2020-12-31$8.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-03
$2.60M
derived: sum of 2 quarters · filed 2022-02-03
$16.00M
derived: sum of 3 quarters · filed 2022-02-03
$12.50M
10-K · filed 2022-02-03
2020-09-30-$6.10M
10-Q · filed 2021-10-20
$7.30M
derived: sum of 2 quarters · filed 2021-10-20
$3.80M
10-Q · filed 2021-10-20
-$1.60M
derived: sum of 4 quarters · filed 2022-02-03
2020-06-30$13.40M
10-Q · filed 2021-07-21
$9.90M
10-Q · filed 2021-07-21
$4.50M
derived: sum of 3 quarters · filed 2022-02-03
$6.20M
derived: sum of 4 quarters · filed 2022-02-03
2020-03-31-$3.50M
10-Q · filed 2021-04-21
-$8.90M
derived: sum of 2 quarters · filed 2022-02-03
-$7.20M
derived: sum of 3 quarters · filed 2022-02-03
$9.60M
derived: sum of 4 quarters · filed 2022-02-03
2019-12-31-$5.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-03
-$3.70M
derived: sum of 2 quarters · filed 2022-02-03
$13.10M
derived: sum of 3 quarters · filed 2022-02-03
$25.70M
10-K · filed 2022-02-03
2019-09-30$1.70M
10-Q · filed 2020-10-19
$18.50M
derived: sum of 2 quarters · filed 2020-10-19
$31.10M
10-Q · filed 2020-10-19
2019-06-30$16.80M
10-Q · filed 2020-07-23
$29.40M
10-Q · filed 2020-07-23
2019-03-31$12.60M
10-Q · filed 2020-04-17
2018-09-30-$300.00K
10-Q · filed 2019-10-18
-$1.20M
10-Q · filed 2019-10-18

Similar stocks

Stock NameCountryMarket CapPE Ratio
Edwards Lifesciences Corp (EW)United States$49.409B51.96
STERIS plc (STE)Ireland$20.343B25.49
ZIMMER BIOMET HOLDINGS, INC. (ZBH)United States$17.103B20.66
ALIGN TECHNOLOGY INC (ALGN)United States$10.346B29.06
MSA Safety Inc (MSA)United States$7.023B21.47
ESTABLISHMENT LABS HOLDINGS INC. (ESTA)$1.954B-65.76
Cadre Holdings, Inc. (CDRE)United States$1.123B33.88
Enovis CORP (ENOV)United States$1.053B-1.18
Anteris Technologies Global Corp. (AVR)United States$0.746B
Sanara MedTech Inc. (SMTI)United States$0.323B-6.81